Standardization of imaging reads for eligibility assessment of patients—component of a risk mitigation strategy in the tanezumab clinical program. (April 2017) - Roemer, F.W.; Miller, C.G.; West, C.R.; Sherlock, S.P.; Brown, M.T.; Kompel, A.J.; Diaz, L.; Galante, N.; Crema, M.D.; Guermazi, A.